Euclidean Capital LLC 23and Me Holding Co. Transaction History
Euclidean Capital LLC
- $779 Million
- Q1 2024
A detailed history of Euclidean Capital LLC transactions in 23and Me Holding Co. stock. As of the latest transaction made, Euclidean Capital LLC holds 10,243,122 shares of ME stock, worth $3.99 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
10,243,122
Previous 10,243,122
-0.0%
Holding current value
$3.99 Million
Previous $9.32 Million
41.77%
% of portfolio
0.7%
Previous 1.05%
Shares
2 transactions
Others Institutions Holding ME
# of Institutions
162Shares Held
122MCall Options Held
197KPut Options Held
229K-
Black Rock Inc. New York, NY21.6MShares$8.41 Million0.0% of portfolio
-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$7.59 Million8.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3MShares$6.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.48MShares$2.92 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$2.49 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $101M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...